Cargando…
Non‐alcoholic fatty liver disease and heart failure with preserved ejection fraction: from pathophysiology to practical issues
The prevalence of non‐alcoholic fatty liver disease (NAFLD) in heart failure (HF) preserved left ventricular ejection fraction (HFpEF) patients could reach 50%. Therefore, NAFLD is considered an emerging risk factor. In 20% of NAFLD patients, the condition progresses to non‐alcoholic steatohepatitis...
Autores principales: | Itier, Romain, Guillaume, Maeva, Ricci, Jean‐Etienne, Roubille, François, Delarche, Nicolas, Picard, François, Galinier, Michel, Roncalli, Jérôme |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006705/ https://www.ncbi.nlm.nih.gov/pubmed/33534958 http://dx.doi.org/10.1002/ehf2.13222 |
Ejemplares similares
-
The Prescription Pattern of Heart Failure Medications in Reduced, Mildly Reduced, and Preserved Ejection Fractions
por: Rastogi, Tripti, et al.
Publicado: (2022) -
Pathophysiological and diagnostic importance of fatty acid-binding protein 1 in heart failure with preserved ejection fraction
por: Harada, Tomonari, et al.
Publicado: (2021) -
Current Understanding of Molecular Pathophysiology of Heart Failure With Preserved Ejection Fraction
por: Budde, Heidi, et al.
Publicado: (2022) -
Conception and bicentric validation of the proSCANNED score, a simplified bedside prognostic score for Heart Failure patients
por: Duflos, Claire, et al.
Publicado: (2021) -
Pathophysiological role of fatty acid‐binding protein 4 in Asian patients with heart failure and preserved ejection fraction
por: Harada, Tomonari, et al.
Publicado: (2020)